PROVENTA INTERNATIONAL

Your catalyst for

Strategic Partnership

Proventa International is a management consulting company, specialising in life sciences business development services, with a truly global reach.

Unique experiences

We’re committed to delivering long-term value across our extensive life science network. Through our carefully crafted meetings, collaborative experiences and services Proventa International can offer you the perfect opportunity to meet your business goals, whatever they may be.

Whether you’re seeking answers to the industry’s biggest challenges, investing in new innovations or hoping to identify your next key partnership – Proventa International can help you get there.

What we offer
Furthering

Drug Discovery

Our events and services provide the ideal opportunity for pharmaceuticals, biotech and service providers to take the next step in the drug development process.

Strategy Meetings
Distinctive events

Strategy Meetings

Intimate format events where senior leadership discuss the biggest challenges facing the industry.

Overview
Investment
Making connections

Investment

Helping launch the next generation of life-changing medicines. Meet the investors hoping to make a difference.

Overview
Consulting
Business development

Consulting

Meet those hard to reach clients, no matter where they are. Personalised services in every corner of the globe.

Overview
LATEST FROM PHARMAFEATURES
About PharmaFeatures

PharmaFeatures provides thought-leading interviews, industry reports and innovative daily content on the newest trends and breaking news across life sciences. In addition to clients within the pharmaceutical space, PharmaFeatures tailors to readers in biotechnology, clinical research, bioinformatics and more.

Pharma Investment Roundup 06-May-2022 06th May 2022 06th May 2022
Daily News

Pharma Investment Roundup 06-May-2022

Follow the movement of money across the pharma industry for the week ending 6 May 22, with multiple moves to advance AI, PROTACs and NK engagers

Overview
Trends in Phenotypic Drug Discovery – A Discussion with Brent Cezairliyan 05th May 2022 05th May 2022
Daily News

Trends in Phenotypic Drug Discovery – A Discussion with Brent Cezairliyan

Phenotypic drug discovery has shown much of its potential in recent years – though key deficiencies remain to be overcome through innovation

Overview
April 2022 Drug Launch Highlights 04th May 2022 04th May 2022
Daily News

April 2022 Drug Launch Highlights

Highlights from drugs approved by the FDA in April 2022 – novel treatments for rare diseases, heart disorders and vaginal yeast infection.

Overview
join life science leaders

Interested? See for yourself

Take the first step and see where Proventa International can take you. Join one of our unique one-day strategy meetings.